Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...
For the first time, researchers have shown that tackling obstructive sleep apnea’s two root causes at once, using both oxygen ...
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a study titled ‘A Phase 2b/3, Randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback